Similar articles for PMID: 9603434

Year	Number of Results
1995	1
1997	2
1998	5
1999	6
2000	8
2001	7
2002	3
2003	6
2004	6
2005	6
2006	8
2007	12
2008	9
2009	3
2010	5
2011	3
2012	2
2013	4
2014	3
2015	6
2016	2
2017	3
2018	4
2019	1
2020	5
2021	5
2022	2
2023	2
2024	0

1

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.

Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J, Hayward NK. Pollock PM, et al. Hum Mutat. 1998;11(6):424-31. doi: 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2. Hum Mutat. 1998. PMID: 9603434

2

The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry.

Lang J, Hayward N, Goldgar D, Tsao H, Hogg D, Palmer J, Stark M, Tobias ES, MacKie R. Lang J, et al. Genes Chromosomes Cancer. 2007 Mar;46(3):277-87. doi: 10.1002/gcc.20410. Genes Chromosomes Cancer. 2007. PMID: 17171691

3

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.

Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; Lund Melanoma Study Group; Melanoma Genetics Consortium (GenoMEL). Goldstein AM, et al. J Med Genet. 2007 Feb;44(2):99-106. doi: 10.1136/jmg.2006.043802. Epub 2006 Aug 11. J Med Genet. 2007. PMID: 16905682 Free PMC article.

4

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J. Hashemi J, et al. Cancer Res. 2000 Dec 15;60(24):6864-7. Cancer Res. 2000. PMID: 11156381

5

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.

Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA. Della Torre G, et al. Br J Cancer. 2001 Sep 14;85(6):836-44. doi: 10.1054/bjoc.2001.1991. Br J Cancer. 2001. PMID: 11556834 Free PMC article.

6

Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.

Maubec E, Chaudru V, Mohamdi H, Blondel C, Margaritte-Jeannin P, Forget S, Corda E, Boitier F, Dalle S, Vabres P, Perrot JL, Lyonnet DS, Zattara H, Mansard S, Grange F, Leccia MT, Vincent-Fetita L, Martin L, Crickx B, Joly P, Thomas L; French Familial Melanoma Study Group; Bressac-de Paillerets B, Avril MF, Demenais F. Maubec E, et al. J Am Acad Dermatol. 2012 Dec;67(6):1257-64. doi: 10.1016/j.jaad.2012.05.014. Epub 2012 Jul 26. J Am Acad Dermatol. 2012. PMID: 22841127

7

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA. Goldstein AM, et al. J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10. doi: 10.1093/jnci/92.12.1006. J Natl Cancer Inst. 2000. PMID: 10861313

8

A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.

Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarrà G, Bressac-de Paillerets B, Goldstein AM. Ciotti P, et al. Am J Hum Genet. 2000 Aug;67(2):311-9. doi: 10.1086/303001. Epub 2000 Jun 22. Am J Hum Genet. 2000. PMID: 10869234 Free PMC article.

9

CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.

Pjanova D, Engele L, Randerson-Moor JA, Harland M, Bishop DT, Newton Bishop JA, Taylor C, Debniak T, Lubinski J, Kleina R, Heisele O. Pjanova D, et al. Melanoma Res. 2007 Jun;17(3):185-91. doi: 10.1097/CMR.0b013e328014a2cd. Melanoma Res. 2007. PMID: 17505264

10

Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.

Auroy S, Avril MF, Chompret A, Pham D, Goldstein AM, Bianchi-Scarrà G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F, Bressac-de Paillerets B; French Hereditary Melanoma Study Group. Auroy S, et al. Genes Chromosomes Cancer. 2001 Nov;32(3):195-202. doi: 10.1002/gcc.1183. Genes Chromosomes Cancer. 2001. PMID: 11579459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year